View in EDS

Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study.

Saved in:
Bibliographic Details
Title: Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study.
Authors: Phadnis S; Division of Pediatrics, Children's of Alabama at The University of Alabama, Birmingham., Wang X; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston., Daw NC; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston., Herzog CE; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston., Subbiah IM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston; Sarah Cannon Research Institute (SCRI), Nashville., Zaky W; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston., Gouda MA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston., Morani AC; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston., Amini B; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston., Harrison DJ; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston., Piha-Paul SA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston., Gorlick R; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston., Schwartz CL; Children's Hospital of Wisconsin, Milwaukee, USA., Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston; Sarah Cannon Research Institute (SCRI), Nashville. Electronic address: Vivek.Subbiah@scri.com.
Source: ESMO open [ESMO Open] 2023 Dec; Vol. 8 (6), pp. 101609. Date of Electronic Publication: 2023 Oct 23.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37879233
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Phadnis+S%22">Phadnis S</searchLink>; Division of Pediatrics, Children's of Alabama at The University of Alabama, Birmingham.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Daw+NC%22">Daw NC</searchLink>; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Herzog+CE%22">Herzog CE</searchLink>; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Subbiah+IM%22">Subbiah IM</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston; Sarah Cannon Research Institute (SCRI), Nashville.<br /><searchLink fieldCode="AU" term="%22Zaky+W%22">Zaky W</searchLink>; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Gouda+MA%22">Gouda MA</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Morani+AC%22">Morani AC</searchLink>; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Amini+B%22">Amini B</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Harrison+DJ%22">Harrison DJ</searchLink>; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Piha-Paul+SA%22">Piha-Paul SA</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Meric-Bernstam+F%22">Meric-Bernstam F</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Gorlick+R%22">Gorlick R</searchLink>; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Schwartz+CL%22">Schwartz CL</searchLink>; Children's Hospital of Wisconsin, Milwaukee, USA.<br /><searchLink fieldCode="AU" term="%22Subbiah+V%22">Subbiah V</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston; Sarah Cannon Research Institute (SCRI), Nashville. Electronic address: Vivek.Subbiah@scri.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2023 Dec; Vol. 8 (6), pp. 101609. <i>Date of Electronic Publication: </i>2023 Oct 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37879233
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.esmoop.2023.101609
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101609
    Titles:
      – TitleFull: Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Phadnis S
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Daw NC
      – PersonEntity:
          Name:
            NameFull: Herzog CE
      – PersonEntity:
          Name:
            NameFull: Subbiah IM
      – PersonEntity:
          Name:
            NameFull: Zaky W
      – PersonEntity:
          Name:
            NameFull: Gouda MA
      – PersonEntity:
          Name:
            NameFull: Morani AC
      – PersonEntity:
          Name:
            NameFull: Amini B
      – PersonEntity:
          Name:
            NameFull: Harrison DJ
      – PersonEntity:
          Name:
            NameFull: Piha-Paul SA
      – PersonEntity:
          Name:
            NameFull: Meric-Bernstam F
      – PersonEntity:
          Name:
            NameFull: Gorlick R
      – PersonEntity:
          Name:
            NameFull: Schwartz CL
      – PersonEntity:
          Name:
            NameFull: Subbiah V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2023 Dec
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2059-7029
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: ESMO open
              Type: main
ResultId 1